Fulminant Giant Cell Myocarditis Requiring Bridge With Mechanical Circulatory Support to Heart Transplantation
暂无分享,去创建一个
G. Sayer | N. Uriel | A. Masoumi | Y. Brailovsky | R. Bijou | E. Oliveros | K. Takeda
[1] L. Cooper,et al. Management of Patients With Giant Cell Myocarditis: JACC Review Topic of the Week. , 2021, Journal of the American College of Cardiology.
[2] L. Cooper,et al. Outcomes of Mechanical Circulatory Support for Giant Cell Myocarditis: A Systematic Review , 2020, Journal of clinical medicine.
[3] E. Ammirati,et al. Biventricular Intravascular Microaxial Blood Pumps and Immunosuppression as a Bridge to Recovery in Giant Cell Myocarditis , 2020, JACC. Case reports.
[4] I. Vítková,et al. Giant cell myocarditis in an older patient – reassessing the threshold for endomyocardial biopsy , 2020, ESC heart failure.
[5] Nisarg Patel,et al. Management of a patient presenting with giant cell myocarditis - A case report. , 2020, Journal of cardiology cases.
[6] S. Dunn,et al. A giant mystery in giant cell myocarditis: navigating diagnosis, immunosuppression, and mechanical circulatory support , 2019, ESC heart failure.
[7] A. Combes,et al. Fulminant giant-cell myocarditis on mechanical circulatory support: Management and outcomes of a French multicentre cohort. , 2018, International journal of cardiology.
[8] K. Salmenkivi,et al. Diagnosis, Treatment, and Outcome of Giant-Cell Myocarditis in the Era of Combined Immunosuppression , 2013, Circulation. Heart failure.
[9] K. Bailey,et al. Usefulness of immunosuppression for giant cell myocarditis. , 2008, The American journal of cardiology.